Skip to main content

Table 1 Drug loading capacities and encapsulation efficiencies of drug loaded into m-HAP

From: Fabrication of 6-gingerol, doxorubicin and alginate hydroxyapatite into a bio-compatible formulation: enhanced anti-proliferative effect on breast and liver cancer cells

System

DL (%)

EE (%)

6-Gin-m-HAP system

3.77 ± 0.55

98.8 ± 0.05

Dox-m-HAP system

23.0 ± 0.33

97.4 ± 0.12

6-Gin + Dox-m-HAP system

20.0 ± 0.12

81.9 ± 0.32